Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol Kit
Product Images NDC 79929-020

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol (NDC 79929-020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte. Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Description)

Image Description (Description)
Chemical structures of desogestrel and ethinyl estradiol are shown, including their molecular formulas C22H30O and C20H24O2, respectively. Both structures depict the detailed arrangement of carbon, hydrogen, and oxygen atoms in steroidal frameworks.*
FDA Label Image

1 (Figure 1)

1 (Figure 1)
A bar chart depicting mortality rates (number of deaths per 100,000 woman-years) across four age groups (15-24, 25-34, 35-44, 45+) comparing four categories: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers). The chart shows higher mortality rates among ever-users who smoke, especially notable in the 45+ age group.*
FDA Label Image

1 (Figure 2)

1 (Figure 2)
A forest plot chart comparing effect estimates of Ever COC vs. Never COC Use and Current COC Use vs. Never-Use from various studies related to hormonal contraceptives. The chart shows odds ratios (OR), relative risks (RR), and hazard ratios (HR) with corresponding confidence intervals, plotted along an effect estimate axis ranging from -1.50 to 2.00.*
FDA Label Image

1 (Figure 3)

1 (Figure 3)
Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol Tablets USP kit showing a 28-day tablet schedule. The label includes circular indicators for days of the week and weeks 1 to 4 with white, yellow, and light green tablet color codes. Storage instructions and NDC 79929-020-05 are also visible. Labeler name Naari Pte. Limited is not depicted in the image.*
FDA Label Image

1 (Figure 4)

1 (Figure 4)
An instructional diagram showing a hand peeling back a strip from a 28-day blister pack of desogestrel and ethinyl estradiol tablets, USP. The strip labels the 'START' and weeks 1 to 4, guiding proper daily tablet placement and use. The kit is labeled with NDC 79929-020-05 and includes dosage strengths of 0.15 mg, 0.02 mg, and 0.01 mg.*
FDA Label Image

Image Description (Figure 5)

Image Description (Figure 5)
A medication guide panel for desogestrel and ethinyl estradiol and ethinyl estradiol tablets, USP, showing a 28-day kit with dosage strengths 0.15 mg, 0.02 mg, and 0.01 mg respectively. The panel displays a weekly layout with circles representing daily tablets color-coded as white, yellow, and light green, organized for four weeks. Storage instructions advise keeping at 20° to 25°C (68° to 77°F) and out of children's reach.*
FDA Label Image

Image Description (Figure 6)

Image Description (Figure 6)
An instructional diagram showing a hand placing a correct day label on a 28-day desogestrel and ethinyl estradiol tablets kit. The kit layout includes 28 circular tablet slots arranged in four rows labeled START, WEEK 2, WEEK 3, and WEEK 4, with instructions to peel and place the day label accordingly.*
FDA Label Image

Image Description (Outer Carton)

Image Description (Outer Carton)
Packaging label for desogestrel and ethinyl estradiol and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and 0.01 mg, in a kit dosage form. The label indicates a 28-day regimen with 3 blister cards each containing 28 tablets. Manufactured for Naari Pte. Limited, Singapore. Includes drug warnings, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.